Yang Luo
Impact in
- Cancer Research top 10%
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation
- Molecular Biology top 10%
- Histone Deacetylase Inhibitors Research
- Epigenetics and DNA Methylation
- Circular RNAs in diseases
- Protein Degradation and Inhibitors
- RNA modifications and cancer
Papers in
-
- RNA modifications and cancer 4
- Ubiquitin and proteasome pathways 3
- Circular RNAs in diseases 3
-
- Cancer-related molecular mechanisms research 5
- MicroRNA in disease regulation 4
- Co-authors
- Ming Zhong (23 shared papers)Minhao Yu (17 shared papers)Shao‐Lan Qin (17 shared papers)Yifei Mu (10 shared papers)Yizhou Huang (7 shared papers)Zhan Yin (1 shared paper)Maozhen Zhang (1 shared paper)Patricia Ruíz (1 shared paper)
- Journals
- Biomedicine & Pharmacotherapy (2 papers)Cancer Letters (1 paper)Journal of Orthopaedic Surgery and Research (1 paper)Cellular Immunology (1 paper)BMJ Open (1 paper)
- Partner nations
- ChinaUnited StatesGermany
In The Last Decade
Yang Luo
39 papers receiving 1.1k citations
Peers
Comparison fields: 5 of 85
- Cancer Research 250
- Molecular Biology 662
- Oncology 235
- Geriatrics and Gerontology 22
- Immunology 91
Countries citing papers authored by Yang Luo
This map shows the geographic impact of Yang Luo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yang Luo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yang Luo more than expected).
Fields of papers citing papers by Yang Luo
This network shows the impact of papers produced by Yang Luo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yang Luo. The network helps show where Yang Luo may publish in the future.
Co-authors
The 25 scholars most cited alongside Yang Luo, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 40 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2007 | 375 | |
| 2 | 2018 | 116 | |
| 3 | 2016 | 72 | |
| 4 | 2018 | 45 | |
| 5 | 2021 | 39 | |
| 6 | 2019 | 35 | |
| 7 | Up-regulated CKS2 promotes tumor progression and predicts a poor prognosis in human colorectal cancer. | 2015 | 35 |
| 8 | 2016 | 34 | |
| 9 | 2015 | 30 | |
| 10 | miR-193b directly targets STMN1 and inhibits the malignant phenotype in colorectal cancer. | 2016 | 29 |
| 11 | 2020 | 27 | |
| 12 | Overexpressed ACP5 has prognostic value in colorectal cancer and promotes cell proliferation and tumorigenesis via FAK/PI3K/AKT signaling pathway. | 2019 | 26 |
| 13 | 2017 | 25 | |
| 14 | 2018 | 23 | |
| 15 | 2021 | 21 | |
| 16 | 2018 | 18 | |
| 17 | 2015 | 17 | |
| 18 | 2020 | 13 | |
| 19 | 2018 | 13 | |
| 20 | Increased expression of Rab5A predicts metastasis and poor prognosis in colorectal cancer patients. | 2015 | 12 |
About Yang Luo
Yang Luo is a scholar working on Molecular Biology, Cancer Research, Oncology, Genetics and Surgery, having authored 40 papers that have together received 1.1k indexed citations. Recurring topics across this work include Cancer-related molecular mechanisms research (5 papers), MicroRNA in disease regulation (4 papers), RNA modifications and cancer (4 papers), Ubiquitin and proteasome pathways (3 papers), Colorectal Cancer Surgical Treatments (3 papers), Inflammatory Bowel Disease (3 papers), Circular RNAs in diseases (3 papers) and Cancer Immunotherapy and Biomarkers (3 papers). The work is most often cited by research in Cancer Research (250 citations), Molecular Biology (662 citations), Oncology (235 citations), Geriatrics and Gerontology (22 citations) and Immunology (91 citations). Yang Luo has collaborated with scholars based in China, United States and Germany. Frequent co-authors include Ming Zhong, Minhao Yu, Shao‐Lan Qin, Yifei Mu, Yizhou Huang, Zhan Yin, Maozhen Zhang, Patricia Ruíz, Tao Wang and Wenting Zhu. Their work appears in journals such as Biomedicine & Pharmacotherapy, Cancer Letters, Journal of Orthopaedic Surgery and Research, Cellular Immunology and BMJ Open.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.